{
    "2018-08-28": [
        [
            {
                "time": "",
                "original_text": "[增持评级]天坛生物(600161)中报点评：血制品业务大幅度提升",
                "features": {
                    "keywords": [
                        "增持评级",
                        "天坛生物",
                        "中报点评",
                        "血制品业务",
                        "大幅度提升"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}